Split History
ETFs Holding CELG »    CELG Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celgene is a biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Co.'s primary commercial stage products include REVLIMID®, POMALYST®/IMNOVID®, OTEZLA®, ABRAXANE®, VIDAZA®, azacitidine for injection (generic version of VIDAZA®) and THALOMID® (sold as THALOMID® or Thalidomide Celgene® outside of the U.S.). In addition, Co. provides other product sales and licensing arrangements. According to our CELG split history records, Celgene has had 4 splits.
CELG split history picture
Celgene (CELG) has 4 splits in our CELG split history database. The first split for CELG took place on April 17, 2000. This was a 3 for 1 split, meaning for each share of CELG owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split. CELG's second split took place on October 25, 2004. This was a 2 for 1 split, meaning for each share of CELG owned pre-split, the shareholder now owned 2 shares. For example, a 3000 share position pre-split, became a 6000 share position following the split. CELG's third split took place on February 27, 2006. This was a 2 for 1 split, meaning for each share of CELG owned pre-split, the shareholder now owned 2 shares. For example, a 6000 share position pre-split, became a 12000 share position following the split. CELG's 4th split took place on June 26, 2014. This was a 2 for 1 split, meaning for each share of CELG owned pre-split, the shareholder now owned 2 shares. For example, a 12000 share position pre-split, became a 24000 share position following the split.

When a company such as Celgene splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the CELG split history from start to finish, an original position size of 1000 shares would have turned into 24000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Celgene shares, starting with a $10,000 purchase of CELG, presented on a split-history-adjusted basis factoring in the complete CELG split history. CELG split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/29/2007
End date: 05/26/2017
Start price/share: $30.81
End price/share: $116.78
Dividends collected/share: $0.00
Total return: 279.03%
Average Annual Total Return: 14.25%
Starting investment: $10,000.00
Ending investment: $37,893.27
Years: 10.00
Date Ratio
04/17/20003 for 1
10/25/20042 for 1
02/27/20062 for 1
06/26/20142 for 1
CELG is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CERE Split History
CGC Split History
CGNT Split History
CHDX Split History
CHE Split History
CHRS Split History
CLBS Split History
CLDN Split History
CLDX Split History
CLRB Split History

Yield10 Bioscience, Inc. (YTEN)
Xerox Corporation (XRX)
Waste Connections, Inc. (WCN)
Spark Energy, Inc. (SPKE)
MagneGas Corporation (MNGA)
Frontier Communications Corporation (FTR)
NeuroMetrix, Inc. (NURO)
Pain Therapeutics, Inc. (PTIE)
Rex Energy Corporation (REXX)
Rexahn Pharmaceuticals, Inc. (RNN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CELG Insider Buying

CELG Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.